ArticleInternational dental journal2026
The Burden and Projections for 2036 of Periodontal Diseases in Asia From 1990 to 2021.
Article in International dental journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Edentulism in China and the Group of Twenty (G20): Epidemiological Trends, Decomposition Analysis, and Forecasts to 2038.International dental journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPeriodontal disease is one of the most common oral diseases in the world and a significant public health challenge. Asia is the region with the highest number of cases. This study comprehensively analyzed the current situation and trends of periodontal diseases in Asia from 1990 to 2021, providing detailed insights into periodontal diseases in the region.
methodThe study employed the open data from the Global Burden of Disease 2021 Database to explore the characteristics of periodontal disease burden in Asia from 1990 to 2021, including the prevalence rate, incidence rate, and changes in disability-adjusted life years. A descriptive analysis of the burden of periodontal diseases in Asia was conducted from multiple dimensions, such as age, gender, and country. The autoregressive integrated moving average model was used to evaluate the trend from 2022 to 2036. Additionally, the Xtreme Gradient Boosting algorithm was used in conjunction with SHapley Additive Explanations for feature importance analysis and model interpretation.
resultIn 2021, there were approximately 684,742,467 patients with periodontal diseases in Asia. South Asia had the highest age-standardized prevalence rate and age-standardized disability-adjusted life years rate (ASDR), while Central Asia had the highest age-standardized incidence rate. The high-income Asia Pacific region exhibited the lowest age-standardized prevalence rate, age-standardized incidence rate, and ASDR. The age group with the highest number of patients was 50 to 54 years old, and the disease was more common in men. The Socio-Demographic Index was negatively correlated with periodontal diseases. The results of SHapley Additive Explanations analyses demonstrate that age is the most influential factor in predicting periodontal disease. Autoregressive integrated moving average model projections suggest that these indicators will remain stable through 2035, indicating that the overall burden of periodontal disease in Asia is expected to plateau rather than continue to rise.
conclusionThe burden of periodontal diseases varies significantly across Asian regions. Therefore, future policy-making should fully consider differences among countries in disease epidemiological characteristics, medical resource distribution, and sociocultural backgrounds, and formulate targeted strategies to effectively reduce the burden of periodontal disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.